Combination unites two innovative diagnostics platforms to build a first-of-its-kind connected point-of-need diagnostics platform

Sapphiros, a diagnostics platform backed by investment funds managed by KKR, and binx health, a point-of-care diagnostics company backed by Hildred, a health care-focused private equity firm, today announced that they have combined to form Onvaro, a next-generation diagnostics company built to bring fast, accurate, and affordable testing to the point of need across health care and consumer settings. As part of this combination, investment funds managed by KKR, through its Health Care Strategic Growth strategy, Hildred, and EQT Life Sciences are investing capital to support Onvaro’s growth trajectory.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.